APPETE INTAKE: A Study on the Effects of Adding an Appetite Engine to a Nutritional Drink (APPETE INTAKE)
Effects of Adding an Appetite Engine to an Oral Nutritional Supplement (ONS) on Dietary Intake in Older Adults in Need of Additional Nutritional Support
The aim of this study is to investigate the effect of adding an appetite engine to a high-protein oral nutritional supplement (ONS) on acute dietary intake in older adults.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Danone
- Phone Number: +31 30 2095 000
- Email: register.clinicalresearchnutricia@danone.com
Study Locations
-
-
-
Krakow, Poland
- Novamedpharm
-
Contact:
- Dr. Nowak
-
Principal Investigator:
- Dr. Nowak
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Adults aged 65 years or older Older adults in need of additional nutritional support, such as those currently using oral nutritional supplements or identified as malnourished or at risk of malnutrition Able to consume oral nutritional drinks as part of daily nutrition Able and willing to provide written informed consent
Exclusion Criteria:
Medical conditions that significantly affect food intake, digestion, or gastrointestinal function Conditions or treatments known to markedly influence appetite or nutritional intake Known allergies or intolerances to components of the nutritional drinks Use of tube feeding or parenteral nutrition Participation in another interventional study during the study period Any condition that, in the investigator's opinion, could interfere with study participation or compliance
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Test ONS with appetite engine
ONS containing appetite engine |
Nutritional drink consumed twice daily |
|
Active Comparator: Control ONS
ONS without appetite engine |
Oral nutritional drink consumed twice daily |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acute dietary intake
Time Frame: Assessed on Day 1 of each intervention period.
|
Amount of energy consumed during a single meal after intake of a nutritional drink. |
Assessed on Day 1 of each intervention period.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Satiety and appetite responses
Time Frame: From before intake up to 120 minutes after intake of the nutritional drink on Day 1 of each intervention period.
|
Participant-reported feelings related to hunger and fullness assessed using standardized questionnaires. |
From before intake up to 120 minutes after intake of the nutritional drink on Day 1 of each intervention period.
|
|
Product adherence
Time Frame: Assessed daily during each intervention period (up to 7 days).
|
Compliance with consumption of the assigned nutritional drink. |
Assessed daily during each intervention period (up to 7 days).
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 24REX0063742
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.